Corsaro, L.; Gentilini, D.; Calzari, L.; Gambino, V.S.
Correction: Corsaro et al. Notch, SUMOylation, and ESR-Mediated Signalling Are the Main Molecular Pathways Showing Significantly Different Epimutation Scores between Expressing or Not Oestrogen Receptor Breast Cancer in Three Public EWAS Datasets. Cancers 2023, 15, 4109. Cancers 2024, 16, 2037.
https://doi.org/10.3390/cancers16112037
AMA Style
Corsaro L, Gentilini D, Calzari L, Gambino VS.
Correction: Corsaro et al. Notch, SUMOylation, and ESR-Mediated Signalling Are the Main Molecular Pathways Showing Significantly Different Epimutation Scores between Expressing or Not Oestrogen Receptor Breast Cancer in Three Public EWAS Datasets. Cancers 2023, 15, 4109. Cancers. 2024; 16(11):2037.
https://doi.org/10.3390/cancers16112037
Chicago/Turabian Style
Corsaro, Luigi, Davide Gentilini, Luciano Calzari, and Vincenzo Sandro Gambino.
2024. "Correction: Corsaro et al. Notch, SUMOylation, and ESR-Mediated Signalling Are the Main Molecular Pathways Showing Significantly Different Epimutation Scores between Expressing or Not Oestrogen Receptor Breast Cancer in Three Public EWAS Datasets. Cancers 2023, 15, 4109" Cancers 16, no. 11: 2037.
https://doi.org/10.3390/cancers16112037
APA Style
Corsaro, L., Gentilini, D., Calzari, L., & Gambino, V. S.
(2024). Correction: Corsaro et al. Notch, SUMOylation, and ESR-Mediated Signalling Are the Main Molecular Pathways Showing Significantly Different Epimutation Scores between Expressing or Not Oestrogen Receptor Breast Cancer in Three Public EWAS Datasets. Cancers 2023, 15, 4109. Cancers, 16(11), 2037.
https://doi.org/10.3390/cancers16112037
